Skip to main content
Psychedex

1Provenance card

the boundary, as counts

Sources

1613 with DOI

1 strong · 9 moderate · 6 weak

Compilations

32026-05-09T09:51:53.841Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

33last ruled 2026-10-02

0 awaiting a ruling

Issued documents

42026-10-02T12:19:00.238Z

notice · info card · emergency

Searches

201 with no results

queries and counts on the build

Claims checked

6948 supported

48 supported · 21 not

Correspondence

0received

consent field ships in Phase 4

Edges

224

derivations recorded for this entity

Complete over 16 sources, 3 compilations, and 33 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/3-meo-pcmo/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-02issueIssued info_card
  2. 2026-10-02srcSyntheses, analytical and pharmacological characterizations of the 'legal high' 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine (3-MeO-PCMo) and analogues
  3. 2026-10-02srcKetamine-Induced Apoptosis in Normal Human Urothelial Cells: A Direct, N-Methyl-d-Aspartate Receptor-Independent Pathway Characterized by Mitochondrial Stress
  4. 2026-10-02src3-MeO-PCP intoxication in two young men: First in vivo detection in Italy
  5. 2026-10-02srcA non-fatal intoxication and seven deaths involving the dissociative drug 3-MeO-PCP
  6. 2026-10-02srcThe risk of emerging new psychoactive substances: The first fatal 3-MeO-PCP intoxication in The Netherlands
  7. 2026-10-02srcIs methoxydine a new rapid acting antidepressant for the treatment of depression in alcoholics?
  8. 2026-10-02srcThe neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia.
  9. 2026-10-02srcNew/emerging psychoactive substances and associated psychopathological consequences
  10. 2026-10-02srcReports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review
  11. 2026-10-02srcIntoxication with 3-MeO-PCP alone: A case report and literature review
  12. 2026-10-02srcThe ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor
  13. 2026-10-02srcNew Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations
  14. 2026-10-02srcPhencyclidine analog use in Sweden--intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project
  15. 2026-10-02srcSigma binding sites in the brain; an emerging concept for multiple sites and their relevance for psychiatric disorders
  16. 2026-10-02src3-MeO-PCMo — PsychonautWiki
  17. 2026-10-02srcSchedules of Controlled Substances: Placement of 3-Methoxyphencyclidine in Schedule I (Final Rule)
  18. 2026-10-02publicationPublication — publishagent-psx
  19. 2026-10-02revisionr1.a1
  20. 2026-10-02rulingRuling — psx:substance/3-meo-pcmo/proposal/article_section_proposals/092104b5-1ebe-4f11-91db-9bb170333b54founder
  21. 2026-10-02rulingRuling — psx:substance/3-meo-pcmo/proposal/article_section_proposals/664825fb-50be-4965-b407-dcc0323e9d4bfounder
  22. 2026-09-04issueIssued emergency
  23. 2026-09-04issueIssued info_card
  24. 2026-09-04issueIssued notice
  25. 2026-06-04proposal27 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  26. 2026-06-04publicationPublication — backfill
  27. 2026-05-09revisionRevision 1
  28. 2026-05-09absenceSearched ClinicalTrials.gov for "3-MeO-PCMo morpholine phencyclidine" — no results
  29. 2026-05-09genGeneration — pipeline-v5 · with 3 morepipeline-v5
  30. 2026-05-09rungeneration run
  31. 2026-05-09rungeneration run
  32. 2026-05-09rungeneration run

The same entries, as forms: six forms.